Acute Kidney Injury News

The nephrology community has faced unique challenges since increasing numbers of people have become infected with the novel coronavirus, deemed COVID-19.

Tacrolimus maintenance over 5 years is well-tolerated and effective among patients with lupus nephritis, according to data published in The Journal of Rheumatology.

In an article published in Kidney Medicine, nephrologists from Mount Sinai Hospital in East Harlem, New York, outline how they are ensuring that patients who require dialysis receive safe and effective care during the COVID-19 pandemic.

The FDA has granted marketing authorization to Medtronic Inc. for a new device designed to provide continuous renal replacement therapy to pediatric patients with AKI or fluid overload, according to a press release from the agency.

The artificial intelligence-enabled clinical diagnostic for kidney disease, known as KidneyIntelX, will be used in a study to determine its predictive ability to assess the risk of adverse kidney events in patients diagnosed with COVID-19, according to a press release from RenalytixAI.

Two of the largest manufacturers of products for patients with kidney-related complications, Fresenius Medical Care North America and Baxter International Inc., have responded to the shortage of dialysis machines and supplies that is affecting hospitals during the COVID-19 pandemic.

Patients with chronic kidney disease who were assigned recombinant human C1 esterase inhibitor, or rhC1INH, before coronary angiography had a lower risk for renal injury compared with those assigned placebo, with a favorable safety profile, especially in those with multiple comorbidities, according to findings from the PROTECT study published in JACC: Cardiovascular Interventions.

Among patients undergoing total hip arthroplasty, acute kidney injury occurs in 1.5% of hospitalizations, and is associated with increased implant infection, health care use and death following surgery, according to findings published in Arthritis Research & Therapy.

Patients with chronic kidney disease who were not given pre-hydration prior to undergoing contrast-enhanced CT experienced outcomes similar to those who were given sodium bicarbonate pre-hydration, according to study results. This led researchers to conclude withholding pre-hydration is safe, as well as cost-effective.

High soluble urokinase plasminogen activator receptor levels were associated with acute kidney injury and may be a pathogenic factor for the condition, according to a study.